Ranking the risks of eighty pharmaceuticals in surface water of a megacity: A multilevel optimization strategy
Miao Chen1, Yajun Hong2, Xiaowei Jin3
1State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences, Beijing 100012, China; College of Environmental Science and Engineering, Tongji University, Shanghai 200092, China.
Abstract:
Pharmaceuticals in freshwater posed ecological risks to aquatic ecosystem, however, most risk assessments of pharmaceuticals were conducted at screening level, which were limited by the availability of the toxicity data. In this study, risks of 80 pharmaceuticals including 35 antibiotics, 13 antiviral drugs, 13 illicit drugs, and 19 antidepressants in surface water of Beijing were assessed with a proposed multilevel environmental risk optimization strategy. Target pharmaceuticals were detected in surface water samples with the detection frequency from 1.7 % to 100 % and the total concentrations from 31.1 ng/L to 2708 ng/L. Antiviral drugs were the dominant pharmaceuticals. Preliminary screening-level risk assessment indicated that 20 pharmaceuticals posed low to high risks with risk quotient from 0.14 (chloroquine diphosphate) to 27.8 (clarithromycin). Thirteen pharmaceuticals were recognized with low to high risks by an optimized risk assessment method. Of them, the refined probabilistic risk assessment of joint probability curves coupling with a quantitative structure activity relationship-interspecies correlation estimation (QSAR-ICE) model was applied. Clarithromycin, erythromycin and ofloxacin were identified to pose low risks with maximum risk products (RP) of 1.23 %, 0.41 % and 0.35 %, respectively, while 10 pharmaceuticals posed de minimis risks. Structural equation modeling disclosed that human land use and climate conditions influenced the risks of pharmaceuticals by indirectly influencing the concentrations of pharmaceuticals. The results indicated that the multilevel strategy coupling with QSAR-ICE model was appropriate and effective for screening priority pollutants, and the strategy can be used to prioritize pharmaceuticals and other emerging contaminants in the aquatic environment.
More Related Videos
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
11:53Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm
Published on: December 9, 2012
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
01:17Design Example: Analyzing Capacity Contours for Flood Risk Assessment
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:28Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
01:03Drug Control Governance: Regulatory Bodies and Their Impact